Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. australasia
  4. biomarker
Show results for
Products

Refine by
Locations
Back to All Locations

  • Australasia
  • American Samoa
  • Australia
  • Fiji
  • Kiribati
  • Marshall Islands
  • Micronesia
  • New Zealand
  • Palau
  • Papua New Guinea
  • Solomon Islands
  • Tonga
  • Tuvalu
  • Vanuatu
Brands

  • confirmmdx
  • mdxhealth
  • selectmdx
Applications

  • actionable molecular-diagnostic-system-for-physicians-medical-health-care-clinical-services

Biomarker Equipment & Supplies In Australasia

3 equipment items found
Available In AustralasiaNear Australasia

SelectMDx - Actionable Molecular Diagnostic System for Prostate Cancer

SelectMDx - Actionable Molecular Diagnostic System for Prostate Cancer

Manufactured by:MDxHealth   based inIrvine, CALIFORNIA (USA)
A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA cancer-related biomarkers (HOXC6 and DLX1).1 The test provides binary results that, when combined with the patient’s clinical risk factors, help the physician determine whether: ...
CONTACT SUPPLIER

MdxHealth - Methylation-Specific PCR Technology (MSP)

MdxHealth - Methylation-Specific PCR Technology (MSP)

Manufactured by:MDxHealth   based inIrvine, CALIFORNIA (USA)
MSP is extremely powerful and accurate with the ability to detect a single cancer cell among 10,000 healthy cells in any type of bodily fluid or tissue. MDxHealth has patents and other intellectual property on the MSP platform and on a broad portfolio of biomarkers targeted at individual genes that are used in its different ...
CONTACT SUPPLIER

ConfirmMDx - Actionable Molecular Diagnostic System for Prostate Cancer

ConfirmMDx - Actionable Molecular Diagnostic System for Prostate Cancer

Manufactured by:MDxHealth   based inIrvine, CALIFORNIA (USA)
ConfirmMDx Addresses Prostate Biopsy Sampling Error and the False-Negative Biopsy Dilemma. “Rule-in” high-risk men who have had a previous negative biopsy result, may be harboring undetected cancer (a false-negative biopsy result), and therefore may benefit from a repeat biopsy and appropriate treatment. “Rule-out” otherwise cancer-free men from undergoing unnecessary ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT